Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors

BACKGROUND: FEZ family zinc finger 1 antisense RNA 1 (FEZF1-AS1), as a novel lncRNA, was reported to be up-regulated in various cancers and involved in tumor progression. This study systematically assessed the prognostic value of FEZF1-AS1 in solid tumors. METHODS: Web of Science, PubMed, EMBASE, Ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi, Yang, Qiu-Xi, Peng, Ting-Ting, Wang, Li-Juan, Xiao, Guo-Liang, Tang, Shu-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587645/
https://www.ncbi.nlm.nih.gov/pubmed/31192939
http://dx.doi.org/10.1097/MD.0000000000015982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587645/
https://www.ncbi.nlm.nih.gov/pubmed/31192939
http://dx.doi.org/10.1097/MD.0000000000015982

Ejemplares similares